Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants.

NCT00003358

NCT00003358
Completed Phase 1

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by a tissue sample examined in a lab
  • You have already had surgery to remove as much of the cancer as possible, followed by chemotherapy that included a drug called cisplatin
  • You have had a second surgical procedure (either a small "keyhole" surgery or a larger abdominal operation) within 8 weeks of joining the trial, which confirmed that any remaining cancer is no larger than 1.0 cm (about the size of a small pea)
  • You are in reasonably good general health, able to carry out normal activities with only minor limitations (confirm with trial site)
  • Your white blood cell count, platelet count, liver function, and kidney function are all within acceptable ranges (confirm with trial site)
  • You already have a working implanted catheter device placed under the skin in your abdomen, used to deliver treatment directly into the abdominal cavity

Who may not be able to join:

  • You have significant nerve damage (such as numbness, pain, or weakness) caused by previous chemotherapy
  • You have a condition that makes it unsafe to receive treatment directly into the abdominal cavity, such as an infection inside the abdomen or extensive internal scar tissue (adhesions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 1
Sponsor
Memorial Sloan Kettering Cancer Center
Registry
clinicaltrials_gov
Start date
1 January 1998
Est. completion
1 January 2001

Where this trial is recruiting

🇺🇸 United States

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov